ArticleFunctional & integrative genomics2026
Cross-species functional transcriptomic analysis distinguishes conserved aging-niche remodeling from inflammatory fibroblast heterogeneity in cardiac aging and heart failure.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac aging is accompanied by inflammatory and extracellular-matrix remodeling, but the extent to which aging-associated fibroblast programs are reproducibly altered in human heart failure remains unclear. We integrated mouse cardiac aging single-cell RNA sequencing, human cardiac aging resources, adult human cardiac fibroblast single-cell data, and two independent human left-ventricular heart-failure cohorts. Mouse fibroblast subclustering identified an old-enriched inflammatory/stress state (Fib0) that expanded from approximately 2.3% of fibroblasts in young mice to 33.4% in old mice. The same discovery-derived signatures were then applied without redefinition to human datasets. A conserved cardiac aging niche score (CCANS) was increased in both heart-failure cohorts and showed a positive random-effects standardized mean difference (Hedges g = 1.04, 95% CI 0.53 to 1.55; P = 6.32 × 10⁻⁵). In contrast, Fib0-marker and inflammatory-fibroblast scores showed marked between-cohort heterogeneity, precluding their interpretation as uniformly reactivated heart-failure states. Adult human heart fibroblast data localized Fib0-like activity to defined fibroblast states, and reanalysis of published IL-1β-stimulated human cardiac fibroblasts supported inducibility of the inflammatory/NF-κB/CEBP core. These findings support conserved remodeling of a cardiac aging niche program across heart failure while identifying context-dependent divergence of individual inflammatory fibroblast signatures.
Indexed as
Identifiers
42538413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.